COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,970 Articles (22,604 medRxiv, 8,366 bioRxiv)

Most recent first Previous |  Page 511: Articles 5101-5110  | Next

Association between SARS-CoV-2 Infection and Select Symptoms and Conditions 31 to 150 Days After Testing among Children and Adults
Zhang, Y., Romieu-Hernandez, A., Boehmer, T. K., Azziz-Baumgartner, E., Carton, T., Gundlapalli, A. V., Fearrington, J., Nagavedu, K., Dea, K., Moyneur, E., Cowell, L. G., Kaushal, R., Mayer, K. H., Puro, J., Rasmussen, S. A., Thacker, D., Weiner, M. G., Saydeh, S., Block, J. P.
10.1101/2022.12.18.22283646 — Posted: 2022-12-19
Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine
Shrestha, N. K., Burke, P. C., Nowacki, A. S., Simon, J. F., Hagen, A., Gordon, S. M.
10.1101/2022.12.17.22283625 — Posted: 2022-12-19
Digital PCR discriminates between SARS-CoV-2 Omicron variants and immune escape mutations
Holland, S. C., Holland, L. A., Smith, M. F., Lee, M. B., Hu, J. C., Lim, E. S.
10.1101/2022.12.19.22283598 — Posted: 2022-12-19
How SARS-CoV-2 alters the regulation of gene expression in infected cells.
Bignon, E., Grandemange, S., Dumont, E., Monari, A.
10.1101/2022.12.18.520908 — Posted: 2022-12-19
Prewhitening and Normalization Help Detect a Strong Cross-Correlation Between Daily Wastewater SARS-CoV-2 RNA Abundance and COVID-19 Cases in a Community
Jeon, M. K., Li, B., Di, D. Y. W., Yan, T.
10.1101/2022.12.16.520829 — Posted: 2022-12-19
High-Throughput Discovery and Characterization of Viral Transcriptional Effectors in Human Cells
Ludwig, C. H., Thurm, A. R., Morgens, D. W., Yang, K. J., Tycko, J., Bassik, M. C., Glaunsinger, B. A., Bintu, L.
10.1101/2022.12.16.520835 — Posted: 2022-12-19
A versatile and interoperable computational framework for the analysis and modeling of COVID-19 disease mechanisms
Niarakis, A., Ostaszewski, M., Mazein, A., Kuperstein, I., Gillespie, M. E., Kutmon, M., Funahashi, A., Acencio, M. L., Hemedan, A., Aichem, M., Klein, K., Czauderna, T., Burtscher, F., Yamada, T. G., Hiki, Y., Hiroi, N. F., Hu, F., Pham, N., Ehrhart, F., Willighagen, E. L., Valdeolivas, A., Dugourd, A., Messina, F., Esteban-Medina, M., Pena-Chilet, M., Rian, K., Soliman, S., Aghamiri, S. S., Puniya, B. L., Naldi, A., Helikar, T., Singh, V., Farinas Fernandez, M., Bermudez, V., Tsirvouli, E., Montagud, A., Noel, V., Ponce de Leon, M., Maier, D., Bauch, A., Gyori, B. M., Bachman, J. A., Luna, A., Pinero, J., Furlong, L., Balaur, I., Rougny, A., Jarosz, Y., Overall, R. W., Phair, R., Perfetto, L., Matthews, L., Rex, D. A. B., Orlic-Milacic, M., Monraz Gomez, L. C., De Meulder, B., Ravel, J. M., Jassal, B., Satagopam, V. P., Wu, G., Golebiewski, M., Gawron, P., Calzone, L., Beckmann, J., Evelo, C., d'Eustachio, P., Schreiber, F., Saez-Rodriguez, J., Dopazo, J., Kuiper, M., Valencia, A., Wolkenhauer, O., Kitano, H., Barillot, E., Auffray, C., Balling, R., Schneider, R., the COVID-19 Disease Map Community
10.1101/2022.12.17.520865 — Posted: 2022-12-19
Evaluation of bivalent Omicron BA.1 booster vaccination after different priming regimens in healthcare workers (SWITCH ON): a randomized controlled trial
Tan, N., Geers, D., Sablerolles, R., Rietdijk, W., Goorhuis, B., Postma, D., Visser, L., Bogers, S., van Dijk, L., Gommers, L., van Leeuwen, L., Boerma, A., Nijhof, S., van Dort, K., Koopmans, M., Dalm, V. A. S. H., Lafeber, M., Kootstra, N. A., Huckriede, A., van Baarle, D., Zaeck, L., GeurtsvanKessel, C., de Vries, R. D., van der Kuy, H.
10.1101/2022.12.18.22283593 — Posted: 2022-12-19
Bacillus Calmette-Guerin vaccine to reduce COVID-19 infections and hospitalisations in healthcare workers: a living systematic review and prospective ALL-IN meta-analysis of individual participant data from randomised controlled trials
ter Schure, J., Ly, A., Belin, L., Benn, C. S., Bonten, M. J. M., Cirillo, J. D., Damen, J. A. A., Fronteira, I., Hendriks, K. D., Junqueira-Kipnis, A. P., Kipnis, A., Launay, O., Mendez-Reyes, J. E., Moldvay, J., Netea, M. G., Nielsen, S., Upton, C. M., van den Hoogen, G., Weehuizen, J. M., Grunwald, P. D., van Werkhoven, H.
10.1101/2022.12.15.22283474 — Posted: 2022-12-19
Comparison of the mucosal and systemic antibody responses in Covid-19 recovered patients with one dose of mRNA vaccine and unexposed subjects with three doses of mRNA vaccines
Liu, S., Tsun, J. G., Fung, G. P., Lui, G. C., Chan, K. Y., Chan, P. K., Chan, R. W.
10.1101/2022.12.16.22283554 — Posted: 2022-12-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).